Logo image of LIMN

LIMINATUS PHARMA INC-CL A (LIMN) Stock Earnings & Estimates

USA - NASDAQ:LIMN - US53271X1081 - Common Stock

1.08 USD
-0.09 (-7.69%)
Last: 11/13/2025, 3:50:39 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024
Revenue
YoY % growth
LIMN revenue by date.LIMN revenue by date.
EBITDA
YoY % growth
LIMN ebitda by date.LIMN ebitda by date.
N/AN/AN/AN/AN/A
EBIT
YoY % growth
LIMN ebit by date.LIMN ebit by date.
-2.53M-1.873M
25.99%		-2.303M
-22.99%		-2.906M
-26.20%
Operating Margin
LIMN operating margin by date.LIMN operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
LIMN eps by date.LIMN eps by date.
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A